Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.

BACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count in...

Full description

Bibliographic Details
Main Authors: Xi Zhang, Yanni Xiao, Qian Ran, Yao Liu, Qianbi Duan, Huiling Duan, Xingde Ye, Zhongjun Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3365127?pdf=render
id doaj-689b13795dea4cc0a53a934189dea56e
record_format Article
spelling doaj-689b13795dea4cc0a53a934189dea56e2020-11-25T02:15:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3691210.1371/journal.pone.0036912Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.Xi ZhangYanni XiaoQian RanYao LiuQianbi DuanHuiling DuanXingde YeZhongjun LiBACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count increment and the hemoglobin increment, respectively, 24 h after transfusion in 105 patients who received HSCT. METHODOLOGY/PRINCIPAL FINDINGS: Using retrospective analysis, we studied whether factors, including gender, time of transplantation, the compatibility of ABO group between HSC donors and recipients, and autologous or allogenic transplantation, influence the efficacy of blood component transfusion. We found that the infection rate of HSCT patients positively correlated with the transfusion amount, and the length of stay in the laminar flow room was associated with transfusion. We found that platelet transfusion performed during HSCT showed significantly better efficacy than that performed before HSCT. The effect of platelet transfusion in auto-transplantation was significantly better than that in allo-transplantation. The efficacy of RBC transfusion during HSCT was significantly lower than that performed before HSCT. The efficacy of RBC transfusion in auto-transplantation was significantly higher than that in allo-transplantation. Allo-transplantation patients who received HSCs from compatible ABO groups showed significantly higher efficacy during both platelet and RBC transfusion. CONCLUSIONS: We conclude that the efficacy of platelet and RBC transfusions does not correlate with the gender of patients, while it significantly correlates with the time of transplantation, type of transplantation, and ABO compatibility between HSC donors and recipients. During HSCT, the infection rate of patients positively correlates with the transfusion amount of RBCs and platelets. The total volume of RBC units transfused positively correlates with the length of the patients' stay in the laminar flow room.http://europepmc.org/articles/PMC3365127?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xi Zhang
Yanni Xiao
Qian Ran
Yao Liu
Qianbi Duan
Huiling Duan
Xingde Ye
Zhongjun Li
spellingShingle Xi Zhang
Yanni Xiao
Qian Ran
Yao Liu
Qianbi Duan
Huiling Duan
Xingde Ye
Zhongjun Li
Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
PLoS ONE
author_facet Xi Zhang
Yanni Xiao
Qian Ran
Yao Liu
Qianbi Duan
Huiling Duan
Xingde Ye
Zhongjun Li
author_sort Xi Zhang
title Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
title_short Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
title_full Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
title_fullStr Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
title_full_unstemmed Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
title_sort clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description BACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count increment and the hemoglobin increment, respectively, 24 h after transfusion in 105 patients who received HSCT. METHODOLOGY/PRINCIPAL FINDINGS: Using retrospective analysis, we studied whether factors, including gender, time of transplantation, the compatibility of ABO group between HSC donors and recipients, and autologous or allogenic transplantation, influence the efficacy of blood component transfusion. We found that the infection rate of HSCT patients positively correlated with the transfusion amount, and the length of stay in the laminar flow room was associated with transfusion. We found that platelet transfusion performed during HSCT showed significantly better efficacy than that performed before HSCT. The effect of platelet transfusion in auto-transplantation was significantly better than that in allo-transplantation. The efficacy of RBC transfusion during HSCT was significantly lower than that performed before HSCT. The efficacy of RBC transfusion in auto-transplantation was significantly higher than that in allo-transplantation. Allo-transplantation patients who received HSCs from compatible ABO groups showed significantly higher efficacy during both platelet and RBC transfusion. CONCLUSIONS: We conclude that the efficacy of platelet and RBC transfusions does not correlate with the gender of patients, while it significantly correlates with the time of transplantation, type of transplantation, and ABO compatibility between HSC donors and recipients. During HSCT, the infection rate of patients positively correlates with the transfusion amount of RBCs and platelets. The total volume of RBC units transfused positively correlates with the length of the patients' stay in the laminar flow room.
url http://europepmc.org/articles/PMC3365127?pdf=render
work_keys_str_mv AT xizhang clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT yannixiao clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT qianran clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT yaoliu clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT qianbiduan clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT huilingduan clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT xingdeye clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
AT zhongjunli clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation
_version_ 1724898070570729472